Large-scale comparative review and assessment of computational methods for anti-cancer peptide identification

Xiao Liang1,2, Fuyi Li3,4,5, Jinxiang Chen1

  • 1College of Information Engineering, Northwest A&F University, Yangling, 712100, China.

Briefings in Bioinformatics
|December 14, 2020
PubMed

Insights

This study reviews computational methods for identifying anti-cancer peptides (ACPs), highlighting their potential in cancer therapy. A new ensemble learning framework, ACPredStackL, is proposed for accurate ACP identification.

Area of Science:

  • Computational biology
  • Bioinformatics
  • Drug discovery

Background:

  • Anti-cancer peptides (ACPs) show promise as targeted cancer therapeutics, sparing healthy cells.
  • Numerous machine learning methods exist for in silico ACP identification, aiding research into their mechanisms.

Purpose of the Study:

  • To comprehensively review and assess existing ACP identification tools.
  • To propose a novel, robust computational framework for enhanced ACP prediction.

Main Methods:

  • Investigated 16 state-of-the-art ACP predictors, analyzing algorithms, feature encoding, and usability.
  • Performed a benchmark performance assessment of existing predictors.
  • Developed and validated a stacking ensemble learning framework (ACPredStackL) using SVM, Naïve Bayesian, lightGBM, and KNN.

Main Results:

  • Identified significant variations in existing ACP prediction methods.
  • Demonstrated that ACPredStackL achieves competitive performance compared to state-of-the-art methods.
  • Provided insights into strategies for improving computational ACP identification models.

Conclusions:

  • Existing ACP identification tools vary widely in their methodologies and performance.
  • The proposed ACPredStackL framework offers a robust and accurate approach for identifying anti-cancer peptides.
  • Freely available webserver and source code facilitate further research and application of ACPredStackL.